We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Weak Point in Deadly Eye Melanoma Identified

News   Sep 10, 2018 | Original story by Julia Evangelou Strait for Washington University School of Medicine in St. Louis

 
Weak Point in Deadly Eye Melanoma Identified

Uveal melanoma, the large green mass pictured, is a cancer of the eye that has no targeted therapies. A new study from Washington University School of Medicine in St. Louis shows that a natural plant compound shuts down uveal melanoma cell growth in human tumor cells grown in the lab. Credit: P. Kumar Rao

 
 
 

RELATED ARTICLES

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Additional Evidence Shows HPV Vaccine is Safe

News

Further evidence has been generated to demonstrate the safety of the life-saving bivalent HPV vaccine.

READ MORE

T Cell Study Uncovers New Hurdle for Developing Immunotherapies

News

There's an unexpected challenge to be overcome - T cell receptors can be more cross-reactive than previously thought.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE